Patent Application
Utility
App. No. 14/629,871
· Confirmation No. 1040
METHODS OF IMPROVING LONG-TERM SURVIVAL AND REDUCING HOSPITALIZATION READMISSION RATES FOR SUBJECTS SUFFERING FROM HEPATIC ENCEPHALOPATHY
Inventor:
Guy Neff
Applicant:
Salix Pharmaceuticals, Ltd
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2016-11-04 | ABN |
Abandonment | 2 | View | |
| 2016-04-20 | CTFR |
Final Rejection | 19 | View | |
| 2016-04-20 | 892 |
List of references cited by examiner | 1 | View | |
| 2016-04-20 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2016-03-07 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2016-03-07 | CLM |
Claims | 2 | View | |
| 2016-03-07 | REM |
Applicant Arguments/Remarks Made in an Amendment | 9 | View | |
| 2016-03-07 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2016-03-07 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2016-03-07 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-03-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2016-03-07 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-12-07 | CTNF |
Non-Final Rejection | 7 | View | |
| 2015-12-07 | 892 |
List of references cited by examiner | 1 | View | |
| 2015-12-07 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2015-12-07 | FOR |
Foreign Reference | 92 | View | |
| 2015-11-24 | OATH |
Oath or Declaration filed | 1 | View | |
| 2015-11-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-06-18 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2015-03-10 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-03-10 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2015-02-24 | TRNA |
Transmittal of New Application | 1 | View | |
| 2015-02-24 | ADS |
Application Data Sheet | 7 | View | |
| 2015-02-24 | SPEC |
Specification | 38 | View | |
| 2015-02-24 | CLM |
Claims | 2 | View | |
| 2015-02-24 | ABST |
Abstract | 1 | View | |
| 2015-02-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2015-02-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-02-24 | 136A |
Authorization for Extension of Time all replies | 2 | View | |
| 2015-02-24 | WFEE |
Fee Worksheet (SB06) | 1 | View |
Inventors
Guy Neff
Tampa, FL
Attorneys & Agents of Record
Classification
USPC
514/279
A61K31/437
Prosecution
- Examiner
- HAVLIN, ROBERT H
- Art Unit
- 1626
- Customer No.
- 75093
- Docket No.
- 119557-14102
- Confirmation No.
- 1040
Publication
- Pub. No.
- US20150164867A1
- Pub. Date
- 2015-06-18
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSH & LOMB PHARMA HOLDINGS CORP.,
DENDREON PHARMACEUTICALS, INC.,
DOW PHARMACEUTICAL SCIENCES, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
OBAGI MEDICAL PRODUCTS, INC.,
OMP, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED,
VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA),
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
SECURITY INTEREST
Recorded 2016-07-18
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/629,871
- Filed
- 2015-02-24
- Pub. No.
- US20150164867A1
- Examiner
- HAVLIN, ROBERT H
- Art Unit
- 1626
External Links